Moneycontrol PRO
Check Credit Score
Check Credit Score
HomeNewsBusinessEarnings

Laurus Labs Q1 PAT down 9% at Rs 15 Cr

Satyanarayana Chava CEO said the API (Active Pharmaceutical Ingredients) Generics business witnessed a slowdown mainly because of lower ARV (antiretroviral) and Hepatitis C API sales.

August 02, 2019 / 07:09 PM IST
Representative image

Representative image

 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Laurus Labs Ltd Profit After Tax for the quarter ended June 30 was down by nine per cent to Rs 15.1 crore against Rs 16.6 crore for the first quarter of last fiscal, the drugmaker said here on Friday. Total net revenues during the quarter was up by two per cent to Rs 550 crore.

It was Rs 539 crore during April-June quarter in FY19, the company said in a press release. V V Ravi Kumar, Executive Director and Chief Financial Officer, said the EBITDA margins were impacted mainly because of lower revenue and higher expenditure related to ramp up in production activities and higher Insurance cost.

Satyanarayana Chava CEO said the API (Active Pharmaceutical Ingredients) Generics business witnessed a slowdown mainly because of lower ARV (antiretroviral) and Hepatitis C API sales.

"As there is a shift in the treatment regime and new tender in South Africa, we are witnessing a deferment in off-take from key customers. We have visibility to recoup growth from the second quarter onwards and hence we remain confident of maintaining the growth trajectory in the Generic API business for FY20," Satyanarayana said.

During the quarter under discussion, the company executed a formulation supply order worth about Rs 80 crore to Low and Middle Income Group Countries (LMIC).

PTI
first published: Aug 2, 2019 07:00 pm

Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347